Home Global Site About Careers Media Centre Home>About About Print Text size view with small font size view with medium font size view with large font size Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. Kyowa Kirin International is owned by Kyowa Hakko Kirin Co., Ltd (KHK) of Japan and is one of Europe’s fastest growing specialty pharmaceutical companies. With more than 300 people employed by the Company, Kyowa Kirin International is headquartered in Scotland with commercial operations throughout the rest of the UK and continental Europe and a US head office. The Company's Development group is located in Galashiels, Scotland and Bedminster, New Jersey, USA. We market a range of specialist products through our commercial operations based in the UK, US, Germany, France, Italy, Spain, Netherlands, Belux, Sweden, Norway, Finland and Denmark. In addition to our links with our parent company, KHK, Kyowa Kirin International has a network of partners who distribute our products in other territories around the world. Kyowa Kirin International was established in Galashiels in the Scottish Borders in 1995. 35 miles South of Scotland’s capital city, Edinburgh. Galashiels is an excellent location from which to build an international pharmaceuticals company. Communications links are strong, with direct links to both Europe and the US out of Edinburgh Airport, and main arterial roads linking the town both North and South. Who to Contact Callum Spreng Corporate Communications DL +44 (0)1896 664103 T +44 (0)1896 664000 E callum.spreng@kyowakirin.com Kyowa Kirin International Head Office Galabank Business Park Galashiels, TD1 1QH United Kingdom T +44 (0) 1896 664000 Back to Top Legal Cookies Sitemap ©2016 Kyowa Kirin International plc.